PharmaCyte Biotech (PMCB) Net Cash Flow (2010 - 2026)
PharmaCyte Biotech's Net Cash Flow came in at -$864,293 for fiscal Q1 2027 (quarter ended Jul 31, 2026), compared with -$1.99 million a year earlier.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Net Cash Flow (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jul 31, 2026, PharmaCyte Biotech reported Net Cash Flow of $4.56 million; for FY2026 (ended Apr 30, 2026), it was $3.43 million.
- Net Cash Flow carries a five-year compound annual growth rate of 21.3% (FY2021 to FY2026).
- Going back by fiscal year, Net Cash Flow was -$35.01 million in FY2025, -$17.86 million in FY2024, -$17.35 million in FY2023 and $83.19 million in FY2022.
- The five-year range for quarterly Net Cash Flow is -$17.55 million (fiscal Q1 2025) to $85.98 million (fiscal Q2 2022).
- Business Quant data shows PMCB's Net Cash Flow at -$1.56 million (Q4 2026), $4.76 million (Q3 2026) and $2.23 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.72 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | -3.52 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -2.82 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 1.53 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 757.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | -3.94 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 1.95 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -4.43 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | -722.00 Mn |
| 10 | PharmaCyte Biotech | 3.79 Mn | -69.05 Mn | - | -864,293.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -864,293.00 |
| Apr 30, 2026 | -1.56 Mn |
| Jan 31, 2026 | 4.76 Mn |
| Oct 31, 2025 | 2.23 Mn |
| Jul 31, 2025 | -1.99 Mn |
| Apr 30, 2025 | -1.21 Mn |
| Jan 31, 2025 | -4.46 Mn |
| Oct 31, 2024 | -11.80 Mn |
| Jul 31, 2024 | -17.55 Mn |
| Apr 30, 2024 | -11.03 Mn |
| Jan 31, 2024 | -12.22 Mn |
| Oct 31, 2023 | -1.24 Mn |
| Jul 31, 2023 | 6.62 Mn |
| Apr 30, 2023 | -4.60 Mn |
| Jan 31, 2023 | -4.32 Mn |
| Oct 31, 2022 | -5.26 Mn |
| Jul 31, 2022 | -3.17 Mn |
| Apr 30, 2022 | -1.24 Mn |
| Jan 31, 2022 | -298,645.00 |
| Oct 31, 2021 | 85.98 Mn |
API Access
PharmaCyte Biotech Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();